If you have been diagnosed with COVID-19 and are at high risk for developing severe COVID-19, you may be eligible for monoclonal antibody treatment, which might prevent you from becoming sicker.<\/p>\n
Antibodies are part of our natural defense against viruses such as SARS-CoV-2, the virus that causes COVID-19. But they take time for the body to make. Antibodies designed to attack COVID-19 have been developed, and in several studies have been shown to reduce the risk of progressing to severe COVID-19 and hospitalization when given early to people who test positive for COVID-19. This therapy is given as an infusion through an IV at one of the UNC Health infusion centers.<\/p>\n
The criteria for patients to be considered for Monoclonal Antibody infusion therapy are:<\/p>\n
Monoclonal antibody therapy needs to be given as soon as possible after symptoms start to workideally within 4 days and no longer than seven days.<\/p>\n
To find out if you are at high risk and eligible for COVID 19 Monoclonal Antibody infusion therapy, please call the UNC COVID Help Line at 888-850-2684, between 8 a.m. and 5 p.m., 7 days a week.<\/p>\n
Providers outside of UNC Health can also call the Help Line for information about whether patients meet detailed criteria and can be referred to a UNC Health clinic for monoclonal antibody treatment. UNC Health providers should check the intranet resources for treatment criteria and referral information.<\/p>\n
<\/p>\n
Go here to see the original: <\/p>\n
Monoclonal antibody infusion therapy for COVID-19 | UNC-Chapel Hill - UNC Chapell Hill<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" If you have been diagnosed with COVID-19 and are at high risk for developing severe COVID-19, you may be eligible for monoclonal antibody treatment, which might prevent you from becoming sicker. Continue reading